Float Short %

0.79

Margin Of Safety %

Put/Call OI Ratio

0.81

EPS Next Q Diff

5.14

EPS Last/This Y

19.94

EPS This/Next Y

0.87

Price

49.11

Target Price

68.19

Analyst Recom

1.97

Performance Q

Relative Volume

0.72

Beta

0.65

Ticker: NVO

21 items of 1

Date	Symbol	Last	P/C OI	P/C Vol	Total OI
2025-10-06	NVO	59.71	0.76	0.31	1292418
2025-10-07	NVO	59.11	0.76	0.61	1309594
2025-10-08	NVO	59.61	0.78	0.51	1329053
2025-10-09	NVO	58.7	0.77	0.59	1340031
2025-10-10	NVO	56.98	0.78	0.80	1353943
2025-10-13	NVO	57.5	0.79	0.80	1319815
2025-10-14	NVO	56.54	0.79	0.79	1337935
2025-10-15	NVO	56.73	0.79	0.82	1352866
2025-10-16	NVO	56.09	0.81	0.71	1368031
2025-10-17	NVO	54.35	0.80	0.74	1360269
2025-10-20	NVO	55.74	0.77	0.67	1195188
2025-10-21	NVO	54.8	0.77	0.53	1248404
2025-10-22	NVO	53.37	0.77	0.82	1274147
2025-10-23	NVO	53.23	0.77	0.70	1310141
2025-10-24	NVO	52.95	0.78	0.51	1326320
2025-10-27	NVO	52.9	0.79	0.77	1290705
2025-10-28	NVO	52.06	0.81	0.82	1334462
2025-10-29	NVO	51.4	0.81	1.32	1361982
2025-10-30	NVO	50.05	0.83	0.59	1405852
2025-10-31	NVO	49.4	0.82	0.55	1460467
2025-11-03	NVO	49.12	0.81	0.55	1406095
Date	Symbol	Last	P/C OI	P/C Vol	Total OI

21 items 1 of 1

21 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-10-06	NVO	59.67	-28.3	-269.7	23.94
2025-10-07	NVO	59.04	-28.3	-968.8	23.74
2025-10-08	NVO	59.62	-28.3	-134.0	23.74
2025-10-09	NVO	58.68	-28.3	-980.0	23.74
2025-10-10	NVO	56.93	-28.3	-1355.3	23.74
2025-10-13	NVO	57.50	-28.3	-995.3	23.74
2025-10-14	NVO	56.67	-30.1	-1305.6	23.74
2025-10-15	NVO	56.73	-30.1	-328.7	23.74
2025-10-16	NVO	56.07	-29.7	-778.9	23.56
2025-10-17	NVO	54.36	-29.7	-1556.2	23.56
2025-10-20	NVO	55.74	-29.7	420.4	23.56
2025-10-21	NVO	54.78	-29.7	-1034.4	23.56
2025-10-22	NVO	53.38	-29.7	-1294.2	23.48
2025-10-23	NVO	53.22	-29.7	-655.3	23.48
2025-10-24	NVO	52.98	-29.7	-724.5	23.48
2025-10-27	NVO	52.89	-29.7	-704.4	23.48
2025-10-28	NVO	52.05	-29.7	-1046.7	23.52
2025-10-29	NVO	51.39	-29.7	-1186.2	23.52
2025-10-30	NVO	50.04	-29.7	-1199.8	23.52
2025-10-31	NVO	49.46	-29.7	-706.2	23.52
2025-11-03	NVO	49.11	-30.7	-54.3	23.51
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

21 items 1 of 1

20 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-10-06	NVO	0	-1.45	0.85
2025-10-07	NVO	0	-1.45	0.85
2025-10-08	NVO	0	-1.45	0.85
2025-10-09	NVO	0	-1.45	0.85
2025-10-10	NVO	0	-1.45	0.93
2025-10-13	NVO	0	-1.41	0.93
2025-10-14	NVO	0	-1.41	0.93
2025-10-16	NVO	0	-1.41	0.93
2025-10-17	NVO	0	-1.41	0.93
2025-10-20	NVO	0	-1.46	0.93
2025-10-21	NVO	0	-1.46	0.93
2025-10-22	NVO	0	-1.46	0.93
2025-10-23	NVO	0	-1.46	0.93
2025-10-24	NVO	0	-1.46	0.93
2025-10-27	NVO	0	-1.50	0.79
2025-10-28	NVO	0	-1.50	0.79
2025-10-29	NVO	0.00	-1.50	0.79
2025-10-30	NVO	0.00	-1.50	0.79
2025-10-31	NVO	0.00	-1.50	0.79
2025-11-03	NVO	0.00	-1.50	0.79
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

20 items 1 of 1

Last Quarter Act. EPS

0.97

Avg. EPS Est. Current Quarter

4.92

Avg. EPS Est. Next Quarter

6.11

Insider Transactions

Institutional Transactions

-1.5

Beta

0.65

Average Sales Estimate Current Quarter

76582

Average Sales Estimate Next Quarter

81025

Fair Value

64.92

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

66.9

Max Drawdown 5-Year %

-68.5

Target Price

68.19

P/E

13.53

Forward P/E

12.39

PEG

1.32

P/S

3.64

P/B

8.25

P/Free Cash Flow

17.42

EPS

3.63

Average EPS Est. Cur. Y

23.51

EPS Next Y. (Est.)

24.38

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

35.6

Relative Volume

0.72

Return on Equity vs Sector %

40.4

Return on Equity vs Industry %

29.7

EPS 1 7Days Diff

EPS 1 30Days Diff

-0.3

EBIT Estimation

-54.3

Novo Nordisk A/S

Sector: Healthcare

Industry: Drug Manufacturers - General

Employees: 78387

Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally. It operates in two segments, Diabetes and Obesity Care, and Rare Disease. The Diabetes and Obesity care segment provides products for diabetes, obesity, cardiovascular, and other emerging therapy areas. The Rare Disease segment offers products in the areas of rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company also provides insulin pens, growth hormone pens, and injection needles. In addition, it offers smart solutions for diabetes treatment, such as smart insulin pens and Dose Check, an insulin dose guidance application. The company has a collaboration agreement with UNICEF to tackle childhood obesity; and with Valo Health, Inc. to discover and develop novel drug programmes for cardiometabolic space. Novo Nordisk A/S was founded in 1923 and is headquartered in Bagsvaerd, Denmark.

stock quote shares NVO – Novo Nordisk A/S Stock Price stock today

news today NVO – Novo Nordisk A/S stock forecast ,stock prediction 2023 2024 2025

marketwatch NVO – Novo Nordisk A/S yahoo finance google finance

stock history NVO – Novo Nordisk A/S invest stock market

stock prices NVO premarket after hours

ticker NVO fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Relative Volume

Beta

Ticker: NVO

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Last Quarter Act. EPS

Average EPS Est. Cur. Y